| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 176.3 | 629.6 | 869.4 | 1,016.0 | 1,163.5 |
| Age-adjusted comparative prevalence of diabetes, % | - | 9.5 | 9.6 | 10.3 | 10.5 |
| People with undiagnosed diabetes, in 1,000s | - | - | 349.9 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 40.2 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 504.0 | 718.9 | 788.6 | 848.5 |
| Age-adjusted comparative prevalence of IGT, % | - | 7.4 | 10.0 | 10.3 | 10.4 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 893.1 | 1,023.2 | 1,188.4 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.8 | 10.1 | 10.4 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 3,741.0 | 6,868.1 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 4.1 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.2 | 0.1 | 0.2 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.3 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 0.9 | - | 1.2 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 2.2 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 536.0 | 604.7 | 630.9 |
| Total diabetes-related health expenditure, ID million | - | - | 1,943.9 | 2,193.0 | 2,288.2 |
| Diabetes-related health expenditure per person, USD | - | 362.0 | 616.5 | 695.5 | 725.7 |
| Diabetes-related health expenditure per person, ID | - | - | 2,235.9 | 2,522.4 | 2,631.8 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 5,555.0 | 7,084.3 | 8,046.4 | 8,750.4 | 9,769.9 |
| Population of children (0-14 y), in 1,000s | 3,506.0 | - | 2,890.9 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 3,682.1 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||